Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sabbagh

Showing results (171-180 of 330) with videos related to

Pageof 33
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2010
Incidental Lewy body disease: clinical comparison to a control cohortCharles H Adler, Donald J Connor, Joseph G Hentz, et al.
European Heart Journal|November 30, 2017
No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient dataPhilip D Harvey, Marwan N Sabbagh, John E Harrison, et al.
Neurology and Therapy|January 19, 2026
Dementia in Progressive Supranuclear Palsy: A Narrative ReviewKathleen S Moore, Yara S Stipho, Nicki Niemann, et al.
Current Alzheimer Research|May 1, 2013
Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier statusMichael Malek-Ahmadi, Thomas Beach, Aleksandra Obradov, et al.
Neurology|April 13, 2005
Smoking affects the phenotype of Alzheimer diseaseM N Sabbagh, S L Tyas, S C Emery, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
The Alzheimer's questionnaire: a proof of concept study for a new informant-based dementia assessmentMarwan N Sabbagh, Michael Malek-Ahmadi, Rahul Kataria, et al.
Dementia and Geriatric Cognitive Disorders|February 2, 2011
The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scoresAnne M Damian, Sandra A Jacobson, Joseph G Hentz, et al.
Dementia and Geriatric Cognitive Disorders|July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's diseaseC G Schipke, O Peters, I Heuser, et al.
Acta Neuropathologica|July 20, 2007
Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment depositsThomas G Beach, Lucia I Sue, Douglas G Walker, et al.
Parkinsonism & Related Disorders|August 31, 2014
Olfactory dysfunction in incidental Lewy body disease and Parkinson's diseaseErika Driver-Dunckley, Charles H Adler, Joseph G Hentz, et al.
Pageof 33

Showing results (171-180 of 330) with videos related to

Sort By:
Pageof 33
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2010
Incidental Lewy body disease: clinical comparison to a control cohortCharles H Adler, Donald J Connor, Joseph G Hentz, et al.
European Heart Journal|November 30, 2017
No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient dataPhilip D Harvey, Marwan N Sabbagh, John E Harrison, et al.
Neurology and Therapy|January 19, 2026
Dementia in Progressive Supranuclear Palsy: A Narrative ReviewKathleen S Moore, Yara S Stipho, Nicki Niemann, et al.
Current Alzheimer Research|May 1, 2013
Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier statusMichael Malek-Ahmadi, Thomas Beach, Aleksandra Obradov, et al.
Neurology|April 13, 2005
Smoking affects the phenotype of Alzheimer diseaseM N Sabbagh, S L Tyas, S C Emery, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
The Alzheimer's questionnaire: a proof of concept study for a new informant-based dementia assessmentMarwan N Sabbagh, Michael Malek-Ahmadi, Rahul Kataria, et al.
Dementia and Geriatric Cognitive Disorders|February 2, 2011
The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scoresAnne M Damian, Sandra A Jacobson, Joseph G Hentz, et al.
Dementia and Geriatric Cognitive Disorders|July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's diseaseC G Schipke, O Peters, I Heuser, et al.
Acta Neuropathologica|July 20, 2007
Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment depositsThomas G Beach, Lucia I Sue, Douglas G Walker, et al.
Parkinsonism & Related Disorders|August 31, 2014
Olfactory dysfunction in incidental Lewy body disease and Parkinson's diseaseErika Driver-Dunckley, Charles H Adler, Joseph G Hentz, et al.
Pageof 33